Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gerritsen

Showing results (171-180 of 224) with videos related to

Pageof 23
Sort By:
The Journal of Gene Medicine|March 18, 2004
Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4Daniëlle A M Heideman, Victor W van Beusechem, Elisabeth Bloemena, et al.
Scientific Reports|March 28, 2017
Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patientsFlorian Wimmers, Nienke de Haas, Anja Scholzen, et al.
Urologic Oncology|December 23, 2020
Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with <sup>225</sup>Ac-PSMA-617 targeted alpha-radiation therapyMaarten J van der Doelen, Niven Mehra, Inge M van Oort, et al.
Journal of Translational Medicine|February 14, 2013
IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cellsSaskia J A M Santegoets, Annelies W Turksma, Megan M Suhoski, et al.
Oncoimmunology|January 18, 2021
Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccinationWouter W van Willigen, Martine Bloemendal, Marye J Boers-Sonderen, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 23, 2018
Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapyM Bloemendal, M J A Rietveld, W W van Willigen, et al.
Oncoimmunology|December 16, 2022
Immunological responses to adjuvant vaccination with combined CD1c<sup>+</sup> myeloid and plasmacytoid dendritic cells in stage III melanoma patientsMartine Bloemendal, Kalijn F Bol, Steve Boudewijns, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectorsTanja D de Gruijl, Sylvia A Luykx-de Bakker, Bryan W Tillman, et al.
Virology|December 23, 2006
A conditionally replicating adenovirus with strict selectivity in killing cells expressing epidermal growth factor receptorJan E Carette, Harm C A Graat, Frederik H E Schagen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2019
Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate CancerJames L Gulley, Michael Borre, Nicholas J Vogelzang, et al.
Pageof 23

Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
The Journal of Gene Medicine|March 18, 2004
Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4Daniëlle A M Heideman, Victor W van Beusechem, Elisabeth Bloemena, et al.
Scientific Reports|March 28, 2017
Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patientsFlorian Wimmers, Nienke de Haas, Anja Scholzen, et al.
Urologic Oncology|December 23, 2020
Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with <sup>225</sup>Ac-PSMA-617 targeted alpha-radiation therapyMaarten J van der Doelen, Niven Mehra, Inge M van Oort, et al.
Journal of Translational Medicine|February 14, 2013
IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cellsSaskia J A M Santegoets, Annelies W Turksma, Megan M Suhoski, et al.
Oncoimmunology|January 18, 2021
Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccinationWouter W van Willigen, Martine Bloemendal, Marye J Boers-Sonderen, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 23, 2018
Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapyM Bloemendal, M J A Rietveld, W W van Willigen, et al.
Oncoimmunology|December 16, 2022
Immunological responses to adjuvant vaccination with combined CD1c<sup>+</sup> myeloid and plasmacytoid dendritic cells in stage III melanoma patientsMartine Bloemendal, Kalijn F Bol, Steve Boudewijns, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectorsTanja D de Gruijl, Sylvia A Luykx-de Bakker, Bryan W Tillman, et al.
Virology|December 23, 2006
A conditionally replicating adenovirus with strict selectivity in killing cells expressing epidermal growth factor receptorJan E Carette, Harm C A Graat, Frederik H E Schagen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2019
Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate CancerJames L Gulley, Michael Borre, Nicholas J Vogelzang, et al.
Pageof 23